In the pharmaceutical industry, adverse events can arise at anytime in a drug’s lifecycle with consequences ranging from damaging to devastating. Once an adverse event is detected, immediate action is required to protect patient safety and meet regulatory mandates for timely reporting. But, with disconnected data silos, separate warehouses for analytics and operations, and the use of inflexible data technologies that require extensive data-modeling processes—it can take months to draw critical insights from the massive volume and variety of available safety information. Learn how MarkLogic gives pharmaceutical companies the power to streamline operations and speed time-to-insight in pharmacovigilance practice.

Auf dieser Website werden Cookies verwendet.

Mit der Nutzung dieser Webseite stimmen Sie der Verwendung von Cookies gemäß der MarkLogic Datenschutzrichtlinie zu.